Aristea Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Aristea Therapeutics's estimated annual revenue is currently $1.3M per year.
- Aristea Therapeutics's estimated revenue per employee is $77,500
- Aristea Therapeutics's total funding is $117.6M.
Employee Data
- Aristea Therapeutics has 17 Employees.
- Aristea Therapeutics grew their employee count by 13% last year.
Aristea Therapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | Chief Medical Officer | Reveal Email/Phone |
2 | Senior Director, Clinical Operations | Reveal Email/Phone |
3 | Senior Director, Operations & Business Development | Reveal Email/Phone |
4 | President & CEO | Reveal Email/Phone |
Aristea Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Aristea Therapeutics?
Aristea Therapeutics (Air-iss-tay-uh) is a clinical-stage drug development company developing novel therapies to treat serious inflammatory diseases. The Aristea team is leveraging its broad industry expertise and proven success in drug development to form synergistic partnerships and build a pipeline of novel drugs. Aristea’s lead program, RIST4721, is currently in Phase 2 clinical development.
keywords:N/A$117.6M
Total Funding
17
Number of Employees
$1.3M
Revenue (est)
13%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Aristea Therapeutics News
Aristea Therapeutics dosed the first patient in its Phase IIb trial of RIST4721 in palmoplantar pustulosis. The drug is a CXCR2 antagonist.
Aristea Therapeutics (Air-iss-tay-uh) is a clinical-stage immunology focused drug development company developing novel therapies to treat...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.8M | 17 | 6% | $21.4M |
#2 | $3.6M | 17 | N/A | N/A |
#3 | $1.5M | 17 | N/A | N/A |
#4 | $1.5M | 17 | N/A | N/A |
#5 | $1.5M | 17 | N/A | N/A |